Home
Health Care Professionals
Sitemap
Search
Diabetes Care
Biopharmaceuticals
About Us
Health care Innovations
Partnering
Media
Careers
Contact Us
Diabetes Care
Levemir®
(insulin determir [rDNA origin] injection)
NovoLog®
(insulin aspart [rDNA origin] injection)
NovoLog® Mix 70/30
(70% insulin aspart protamine suspension and 30% insulin aspart injection, [rDNA origin])
Biopharmaceuticals
Hemostasis
Norditropin®
(somatropin [rDNA origin] injection)
Women's Health - Hormone Therapy
Learn More
Close
Your Well-Being
Helping you treat diabetes
Living with diabetes
Manage your diabetes
Share your story
Loud and clear: Young Voices speak out
Your Treatment
Our products, your health
Patient Resources
Novo Nordisk Care
Innovations
Close
Your Well-Being
What is hemophilia with inhibitors
Support Programs
SevenSECURE®
Insurance
The Changing Possibilities Coalition
Living with hemophilia with inhibitors
Read Ashley's story
Read Alex and Adam's story
Read Robert's story
Your Treatment
Our products, your health
Close
What is Diabetes
Learning about diabetes
Guide me
What is Hemophilia with Inhibitors
Raising Awareness
Medical Screening
National Diabetes Goal
The Changing Possibilities Coalition
Hemophilia Support Programs
SevenSECURE®
Insurance
Working for Change
National Changing Diabetes® Program
World Diabetes
Foundation
The Novo Nordisk Hemophilia Foundation
Safe at School
We're interested in you. Contact us to learn about our resources.
patient or caregiver
health care professional
career seeker
media professional
business partner
Visit Novo Nordisk Global
Jan 25, 2010
Novo Nordisk's Victoza® Receives FDA Approval for Adults With Type 2 Diabetes
Jan 21, 2010
Novo Nordisk Makes FORTUNE's List of '100 Best Companies to Work For'
Visit Novo Nordisk
Global
